Advertisement

Viral Oncogenes and Cellular Prototypes

  • P. Duesberg
  • M. Nunn
  • T. Biehl
  • W. Phares
  • W.-H. Lee
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 28)

Summary

The structural hallmark of retroviral transforming onc genes is a specific RNA sequence that is unrelated to the essential retroviral genes but closely related to certain cellular prototypes termed proto-onc genes. Two types of onc genes have been distinguished. Type I are onc genes which utilize elements of specific sequences only to encode a transforming protein. Type II onc genes are hybrids which utilize essential viral (typically gag) and specific RNA sequences to encode transforming proteins. Comparisons between viral onc genes and cellular proto-onc genes are reviewed in the light of two competing models for proto-onc function: the quantitative model, which holds that viral onc genes and cellular proto-onc genes are functionally the same and that transformation is the result of enhanced dosage of a cellular proto-onc gene; and the qualitative model, which holds that they are different. Structural comparisons between viral onc genes and cellular prototypes have demonstrated extensive sequence homologies in the primary structures of the specific sequences. However, qualitative differences exist in the structure and organization of viral onc genes and cellular prototypes. These include differences in promoters, minor differences in the primary structure of shared sequences, and absolute differences such as in the presence of sequences which are unique to viral onc genes or to corresponding cellular genetic units. For example, type II hybrid onc genes of retroviruses share only their specific but not their gag-related elements with the cell, and cellular proto-onc genes are interrupted by sequences of nonhomology relative to viral onc genes. In addition, proto-onc gene units may include unique cellular coding sequences not shared with viral onc genes. There is circumstantial evidence that some proto-onc genes are potentially oncogenic after activation (quantitative model) or modification (qualitative model). Activated by an adjacently integrated retroviral promotor, the cellular prototype of the onc gene of the avian acute leukemia virus MC29 was proposed to cause lymphoma and activated by ligation with viral promoter sequences two proto-onc DNAs, those of Moloney and Harvey sarcoma viruses, were found to transform mouse 3T3 cell lines. Mutations presumably conferred 3T3 cell-transforming ability to the proto-onc gene of Harvey sarcoma virus that has been isolated from a human bladder carcinoma cell line. In no case has an unaltered proto-onc as yet been shown to be necessary and sufficient for carcinogenesis. Despite this and structural differences between viral onc genes and cellular proto-onc genes, we cannot at present conclusively distinguish between the quantitative and the qualitative models because a genetic and functional definition of most viral onc genes and of all cellular prototypes of viral onc genes are not as yet available.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bishop JM (1981) Enemies within: the genesis of retrovirus oncogenes. Cell 23:5–6PubMedCrossRefGoogle Scholar
  2. 2.
    Bishop JM, Courtneidge SA, Levinson AD, Oppermann H, Quintrell N, Sheiness DK, Weiss SR, Varmus HE (1980) The origin and function of avian retrovirus transforming genes. Cold Spring Harbor Symp Quant Biol 44:919–930PubMedGoogle Scholar
  3. 3.
    Bister K, Duesberg PH (1982) Genetic structure and transforming genes of avian retroviruses: In: Klein G (ed) Advances in viral oncology, vol 1. Raven, New York pp 3–42Google Scholar
  4. 4.
    Bister K, Nunn M, Moscovici C, Perbal B, Baluda MA, Duesberg PH (1982) E26 and AMV: two acute leukemia viruses with related transformation-specific RNA sequences, but different genetic structures, gene products and oncogenic properties. Proc Natl Acad Sci 79:3677–3681PubMedCrossRefGoogle Scholar
  5. 5.
    Cooper GA, Neiman PE (1981) Two distinct candidate transforming genes of lymphoid leukosis virus-induced neoplasms. Nature 292: 857–858PubMedCrossRefGoogle Scholar
  6. 6.
    DeFeo D, Gonda MA, Young HA, Chang EH, Lowy DR, Scolnick EM, Ellis RW (1981) Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci USA 78:3328–3332PubMedCrossRefGoogle Scholar
  7. 7.
    Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79: 3637–3640PubMedCrossRefGoogle Scholar
  8. 8.
    Duesberg PH (1980). Transforming genes of retroviruses. Cold Spring Harbor Symp Quant Biol 44: 13–29PubMedGoogle Scholar
  9. 9.
    Duesberg PH, Bister K, Moscovici C (1980) Genetic structure of avian myeloblastosis virus released from transformed myeloblasts as a defective virus particle. Proc Natl Acad Sci 77:5120–5124PubMedCrossRefGoogle Scholar
  10. 10.
    Duesberg PH, Robins T, Lee W-H, Bister K, Garon C, Papas T (1982) On the relationship between the transforming onc genes of avian Rous sarcoma and MC29 viruses and homologous loci of the chicken cell. In: Revoltella R et al. (eds) Expression of differentiated functions in cancer cells. Raven, New York, pp 471–484Google Scholar
  11. 11.
    Eva A, Robbins KC, Andersen PR, Srinivasan A, Tronick SR, Reddy EP, Ellmore NW, Galen AT, Lautenberger JA, Papas TS, Westin E-H, Wong-Staal F, Gallo RC, Aaronson SA (1982) Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature 295: 116–119PubMedCrossRefGoogle Scholar
  12. 12.
    Frankel AE, Fischinger PJ (1976) Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci USA 73:3705–3709PubMedCrossRefGoogle Scholar
  13. 13.
    Gross L (1970) Oncogenic, viruses. Pergamon, New YorkGoogle Scholar
  14. 13a.
    Graf T, Beug H, Hayman MJ (1980) Target cell specificity of defective avian leukemia viruses: Haematopoietic target cells for a given virus type can be infected but not transformed by strains of a different type. Proc Natl Acad Sci USA 77: 389–393PubMedCrossRefGoogle Scholar
  15. 14.
    Hayward WS, Neel BG, Astrin SM (1981). Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature, 290:475–480PubMedCrossRefGoogle Scholar
  16. 15.
    Huebner RJ, Todaro GJ (1969). Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 64: 1087–1094PubMedCrossRefGoogle Scholar
  17. 16.
    Kettmann R, Deschamps J, Cleuter Y, Couez D, Burny A, Marbaix G (1982). Leukemogenesis by bovine leukemia virus: Proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3′ proximate cellular sequences. Proc Natl Acad Sci USA 79: 2465–2469PubMedCrossRefGoogle Scholar
  18. 17.
    Lee W-H (1981) Identificaiton and characterization of the transforming gene of Fujinami sarcoma virus and the seuqence relationship of the src gene of Rous sarcoma viruses and the cellular src locus in chicken. PhD Thesis, University of California, BerkeleyGoogle Scholar
  19. 18.
    Lee W-H, Bister K, Pawson A, Robins T, Moscovici C, Duesberg PH (1980) Fujinami sarcoma virus: An avian RNA tumor virus with a unique transforming gene. Proc Natl Acad Sci USA 77:2018–2022PubMedCrossRefGoogle Scholar
  20. 19.
    Lee W-H, Nunn M, Duesberg PH (1981) Src genes of ten Rous sarcoma virus strains, including two reportedly transduced from the cell, are completely allelic; Putative markers of transduction are not detected. J Virol 39:758–776PubMedGoogle Scholar
  21. 20.
    Lee W-H, Liu C-P, Duesberg PH (1982) DNA clone of avian Fujinami sarcoma virus temperature-sensitive in maintenance of transformation of mammalian cells. J Virol 44:401–412PubMedGoogle Scholar
  22. 21.
    Mellon P, Pawson A, Bister K, Martin GS, Duesberg PH (1978) Specific RNA sequences and gene products of MC29 avian acute leukemia virus. Proc Natl Acad Sci USA 75:5874–5878PubMedCrossRefGoogle Scholar
  23. 22.
    Moscovici C, Samarut J, Gazzolo L, Moscovici MG (1981) Myeloid and erythroid neoplastic responses to avian defective leukemia viruses in chickens and in quail. Virology 113: 765–768PubMedCrossRefGoogle Scholar
  24. 23.
    Oskarsson MK, McClements WL, Blair DS, Maizel JV, Vande Woude GF (1980) Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science 207: 1222–1224PubMedCrossRefGoogle Scholar
  25. 24.
    Parada LF, Tobin CJ, Shih C, Weinberg RA (1982) Human EJ bladder carcinoma oncogene is a homologue of Harvey Sarcoma Virus ras gene. Nature 297:474–478PubMedCrossRefGoogle Scholar
  26. 25.
    Parker RC, Varmus HE, Bishop JM (1981) Cellular homologue (c-src) of the transforming gene of Rous sarcoma virus: Isolation, mapping, and transcriptional analysis of c-src and flanking regions. Proc Natl Acad Sci USA 78:5842–5846PubMedCrossRefGoogle Scholar
  27. 26.
    Payne GA, Bishop JM, Varmus HE (1982) Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature 293:209–214CrossRefGoogle Scholar
  28. 26a.
    Rechavi G, Givol D, Canaani E (1982) Activation of a cellular oncogene by DNA rearrangement: Possible involvement of an IS-like element. Nature 300:607–611PubMedCrossRefGoogle Scholar
  29. 27.
    Rigby PWI (1982) The oncogenic circle closes. Nature 297: 451–453PubMedCrossRefGoogle Scholar
  30. 28.
    Robins T, Bister K, Garon C, Papas T, Duesberg P (1982) Structural relationship between a normal chicken DNA locus and the transforming gene of the avian acute leukemia virus MC29. J Virol 41:635–642PubMedGoogle Scholar
  31. 29.
    Rushlow KE, Lautenberger JA, Papas TS, Baluda MA, Perbal B, Chirikjian JG, Reddy P (1982) Nucleotide sequence of the transforming gene of avian myeloblastosis virus. Science 216: 1421–1426PubMedCrossRefGoogle Scholar
  32. 29a.
    Saedler H, Reif HJ, Hu S, Davidson N (1974) IS2, a genetic element for turn-off and turn-on of gene activity in E. coli. Molec Gen Genet 132:265–289PubMedCrossRefGoogle Scholar
  33. 30.
    Scolnick EM, Parks WP (1974) Harvey sarcoma virus: A second murine type C sarcoma virus with rat genetic information. J Virol 13: 1211–1219PubMedGoogle Scholar
  34. 31.
    Shalloway D, Zelenetz AD, Cooper GM (1981) Molecular cloning and characterization of the chicken gene homologous to the transforming gene of Rous sarcoma virus. Cell 24:531–542PubMedCrossRefGoogle Scholar
  35. 31a.
    Shilo B-Z, Weinberg RA (1981) DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster. Proc Natl Acad Sci USA 78: 6789–6792PubMedCrossRefGoogle Scholar
  36. 32.
    Spector D, Varmus HE, Bishop JM (1978) Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in the DNA of uninfected vertebrates. Proc Natl Acad Sci 75:4102–4106PubMedCrossRefGoogle Scholar
  37. 33.
    Stehelin D, Varmus HE, Bishop JM, Vogt PK (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170–173PubMedCrossRefGoogle Scholar
  38. 34.
    Stehelin D, Saule S, Roussel M, Sergeant A, Lagrou C, Rommens C, Raes MB (1980) Three new types of viral oncogenes in defective avian leukemia viruses: I. Specific nucleotide sequences of cellular origin correlate with specific transformation. Cold Spring Harbor Symp Quant Bioi 44: 1215–1223.Google Scholar
  39. 35.
    Takeya T, Hanafusa H, Junghans RP, Ju G, Skalka AM (1981) Comparison between the viral transforming gene (src) of recovered avian sarcoma virus and its cellular homolog. Mol Cell Biol 1: 1024–1037PubMedGoogle Scholar
  40. 36.
    Temin HM (1971) The protovirus hypothesis: Speculations on the significance of RNA directed DNA synthesis for normal development and for carcinogenesis. J Natl Cancer Inst 46:3–7PubMedGoogle Scholar
  41. 36a.
    Todaro GJ, Huebner RJ (1972) The viral oncogene hypothesis: New evidence. Proc Natl Acad Sci USA 69: 1009–1015PubMedCrossRefGoogle Scholar
  42. 37.
    Tooze J (1973) The molecular biology of tumour viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New YorkGoogle Scholar
  43. 38.
    Tsichlis PN, Coffin JM (1980) Role of the C region in relative growth rates of endogenous and exogenous avian oncoviruses. Cold Spring Harbor Symp Quant Biol 44: 1123–1132PubMedGoogle Scholar
  44. 38a.
    Van Beveren CV, van Straaten F, Galleshaw JA, Verma IM (1981) Nucleotide sequence of the genome of a murine sarcoma virus. Cell 27:97–108PubMedCrossRefGoogle Scholar
  45. 38b.
    Watanabe S, Temin HM (1982) Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc Natl Acad Sci USA 79:5986–5990PubMedCrossRefGoogle Scholar
  46. 39.
    Weinberg R (1982) Use of transfection to analyze genetic information and malignant transformation. Biochimica et Biophysica Acta 651: 25–35Google Scholar
  47. 40.
    Weiss RA, Teich NM, Varmus H, Coffin JM (1982) The molecular biology of tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New YorkGoogle Scholar
  48. 41.
    Wong T-E, Lai MM-C, Hu SF, Hirano A, Vogt PK (1982) Class II defective avian sarcoma viruses: comparative analysis of genome structure. Virology 120:453–464PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • P. Duesberg
  • M. Nunn
  • T. Biehl
  • W. Phares
  • W.-H. Lee

There are no affiliations available

Personalised recommendations